Anti-hepatitis medical combination
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGYIN TIANJIANG PHARMA
- Publication Date
- 2007-10-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
1. Technical field
[0001] The invention belongs to the technical field of medicine, and relates to a combination of glycyrrhizic acid or a pharmaceutically acceptable salt thereof, tiopronin, matrine and silybin or one or more of its derivatives or silymarin and red Pharmaceutical composition made from sedum rosea or rhodiola rosea extract and its preparation method. 2. Background technology
[0002] Liver diseases generally include hepatitis, cirrhosis, and liver cancer. Viral hepatitis caused by hepatitis virus has always been one of the serious infectious diseases in the world. More and more, such as hepatitis B, hepatitis C and other common viral hepatitis has become a clinical refractory disease, and has even become the main cause of liver cirrhosis and liver cancer. Due to the many etiologies of this type of disease, the difficulty in turning the virus negative, the long course of the disease, and the poor prognosis of some patients, it has caused great physical and ...